Upcoming Events
Search Result For "Drugdiscovery".
- Event Type
- Event Category
- Event Country
- Event Date
Event Type
Categories
Country
City
Date
With Nintedanib and Pirfenidone set to lose their patents in the next 3-6 years, Pliant Therapeutics moving into phase 2b, readouts expected from F...
Europe's leading Protein Degradation congress is back - uniting leading experts in the field of targeted protein degradation and beyond to accelera...
In 2023, industry is witnessing a renaissance in viral vector characterization. Spurred by widespread biopharma investment to engineer a new wave o...
2023 is booming with novel psychiatric R AND D and the promise of precision medicine for neuropsychiatric patients. Pipelines are gaining momentum,...
With lipid nanoparticles moving beyond mRNA vaccines, biopharma are racing against the clock to exploit clinical utility to deliver more complex pa...
Amongst the latest innovations in patient-derived iPSC models, 3D brain organoid models, advances in artificially driving neurodegeneration in vivo...
CRISPR-based therapies are undergoing a remarkable evolution, with drug developers striving to enhance the safety, precision and efficacy of their ...
This Fall, the world's longest-standing and most comprehensive TPD meeting, the 6th TPD Summit, returns to Boston in 2023 as the trusted, definitiv...
Despite a challenging 2022 for Gene Therapy developers targeting the CNS, the recent approvals of Skysona by bluebird bio and Upstaza by PTC Therap...
Behind regulatory milestones like the recent accelerated FDA approval for Duchenne Muscular Dystrophy, robust and detailed analytics are the corner...
The 5th Inflammasome Therapeutics Summit returns to Boston to unite industry pioneers at a critical time as clinical readouts are expected, and a w...
As neuroscience R and D surges with investment to solve the field's most pressing challenge, access to the brain, the 5th CNS Drug Development Summ...